Everything you need to win Catalyst Clinical Research — in one platform.
Who to reach, what to say, and why now on Catalyst Clinical Research — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Catalyst Clinical Research — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
The decision-maker’s email and mobile — dial in-browser.
Kristin Judge Appointed As Chief Commercial Officer At Catalyst Clinical Research
RECENTLY ACQUIREDAug 08, 2024•almost 2 years ago
Company
Catalyst Clinical Research
WilmingtonBiotechnology
Description
Kristin Judge has been appointed as the first chief commercial officer (CCO) at Catalyst Clinical Research, assuming the role on July 29, 2024. In her new position, Kristin will lead the company's commercial functions and is expected to support Catalyst's continued growth with her extensive experience in supporting biotech and pharmaceutical customers with CRO services and life-sciences technologies.
Company Information
Company
Catalyst Clinical Research
Location
Wilmington, North Carolina, United States
About
Catalyst is a clinical development organization providing highly customizable clinical research solutions to the global biopharmaceutical industry through two established solutions: Catalyst Flex and Catalyst Oncology. With more than 700 staff across 35 countries, the company provides multi-therapeutic global resourcing and functional services through Catalyst Flex and a full-service oncology CRO offering through Catalyst Oncology. The company's flexible service model is built from more than a decade of listening to customers, devising customer-centric solutions, and helping them drive breakthrough clinical development studies leveraging Catalyst's expert teams and innovative technologies.
WilmingtonBiotechnology